Answer from: Radiation Oncologist at Academic Institution
The Stanford experience published by King et al was an important one describing a prospective experience of SBRT at dose levels of 35-36.25 Gy, and these dose levels were used based upon prior single institution retrospective reports from community practice settings where a good deal of experience ...
Comments
Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School The data as reported by Meier et al in this months...
Answer from: Radiation Oncologist at Academic Institution
The King analysis of over 1,100 patients from multi-center phase II studies is currently the strongest evidence setting the bar at 35-40 Gy in 5 fractions, with no evidence of a dose-response in biochemical outcomes over this range. Most modern SBRT reports fall within this range, and the RTOG/NRG s...
The data as reported by Meier et al in this months...